SCHEMBL28656244

SCHEMBL28656244

CCCCOc1nc(N)c2[nH]c(=O)n(Cc3ccc(CN4CCC(CCNC(=O)CCC(CCC(=O)NCCC5CCN(Cc6ccc(Cn7c(=O)[nH]c8c(N)nc(OCCCC)nc87)cc6)CC5)NC(=O)OC(C)(C)C)CC4)cc3)c2n1

nearest known ligand 0.55

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ TLR7 Q9NYK1 19/20 0.55
▸ IL6 P05231 10/20 0.55
▸ BCHE P06276 1/20 0.54
▸ ACHE P22303 1/20 0.54
▸ TLR8 Q9NR97 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26354284 0.92 TLR7 (0.48) TLR7IL6BCHEACHETLR8
SCHEMBL26359789 0.91 TLR7 (0.55) TLR7IL6TLR8
SCHEMBL26354074 0.90 TLR7 (0.66) TLR7IL6TLR8
SCHEMBL26347756 0.90 TLR7 (0.60) TLR7IL6TLR8
SCHEMBL26347721 0.88 TLR7 (0.64) TLR7IL6TLR8
SCHEMBL26358175 0.87 TLR7 (0.59) TLR7IL6TLR8
SCHEMBL29034558 0.86 TLR7 (0.52) TLR7IL6TLR8
SCHEMBL29475652 0.85 TLR7 (0.65) TLR7IL6TLR8
SCHEMBL22347092 0.85 TLR7 (0.65) TLR7IL6TLR8
SCHEMBL26347251 0.85 TLR7 (0.59) TLR7IL6TLR8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116457023-A antibody-TLR agonist conjugates, methods and uses thereof AMBRX公司 2023-07-18 — — CN disclosed
EP-4199968-A1 ANTIBODY-TLR AGONIST CONJUGATES, METHODS AND USES THEREOF Ambrx, Inc. (US) 2023-06-28 — — EP disclosed
WO-2022040596-A1 ANTIBODY-TLR AGONIST CONJUGATES, METHODS AND USES THEREOF AMBRX, INC. (US) 2022-02-24 — — WO disclosed
CN-113660957-A Compositions, methods, and uses comprising antibody-TLR agonist conjugates AMBRX公司 2021-11-16 — — CN disclosed
Send feedback